VOYA Investment Management
EBS icon

VOYA Investment Management’s Emergent Biosolutions EBS Stock Holding History

VOYA Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.9K Buy
+10,371
New +$86.8K ﹤0.01% 2371
2025
Q3 		– Sell
-14,692
Closed -$93.7K – 2502
2025
Q2 		$93.7K Buy
+14,692
New +$84.1K ﹤0.01% 2503
2024
Q2 		– Sell
-18,520
Closed -$46.9K – 2848
2024
Q1 		$46.9K Sell
18,520
-1,544
-8% -$3.48K ﹤0.01% 2736
2023
Q4 		$48.2K Hold
20,064
– – ﹤0.01% 2854
2023
Q3 		$68.2K Hold
20,064
– – ﹤0.01% 2813
2023
Q2 		$147K Buy
20,064
+759
+4% +$7.04K ﹤0.01% 2684
2023
Q1 		$200K Hold
19,305
– – ﹤0.01% 2539
2022
Q4 		$228K Hold
19,305
– – ﹤0.01% 2508
2022
Q3 		$405K Hold
19,305
– – ﹤0.01% 2158
2022
Q2 		$599K Hold
19,305
– – ﹤0.01% 1718
2022
Q1 		$793K Buy
19,305
+205
+1% +$9.04K ﹤0.01% 1630
2021
Q4 		$831K Sell
19,100
-25,850
-58% -$1.17M ﹤0.01% 1673
2021
Q3 		$2.25M Sell
44,950
-804
-2% -$48.7K ﹤0.01% 1121
2021
Q2 		$2.88M Buy
45,754
+12,772
+39% +$821K 0.01% 1051
2021
Q1 		$3.06M Buy
32,982
+1,163
+4% +$119K 0.01% 1003
2020
Q4 		$2.85M Buy
31,819
+3,367
+12% +$309K 0.01% 997
2020
Q3 		$2.94M Sell
28,452
-168,623
-86% -$18.2M 0.01% 895
2020
Q2 		$15.6M Sell
197,075
-25,157
-11% -$1.87M 0.04% 399
2020
Q1 		$12.9M Sell
222,232
-9,747
-4% -$562K 0.03% 407
2019
Q4 		$12.5M Sell
231,979
-161,667
-41% -$8.77M 0.03% 539
2019
Q3 		$20.6M Sell
393,646
-61,784
-14% -$2.88M 0.05% 366
2019
Q2 		$22M Buy
455,430
+57,814
+15% +$2.77M 0.05% 363
2019
Q1 		$20.1M Buy
397,616
+28,546
+8% +$1.68M 0.05% 374
2018
Q4 		$21.9M Buy
369,070
+320,099
+654% +$20.6M 0.05% 328
2018
Q3 		$3.22M Sell
48,971
-9,169
-16% -$535K 0.01% 939
2018
Q2 		$2.94M Buy
58,140
+1,835
+3% +$95.6K 0.01% 959
2018
Q1 		$2.96M Buy
56,305
+5,808
+12% +$289K 0.01% 938
2017
Q4 		$2.35M Buy
50,497
+18,020
+55% +$759K ﹤0.01% 1001
2017
Q3 		$1.31M Buy
32,477
+6,404
+25% +$232K ﹤0.01% 1237
2017
Q2 		$884K Sell
26,073
-3,602
-12% -$111K ﹤0.01% 1476
2017
Q1 		$862K Sell
29,675
-22,306
-43% -$679K ﹤0.01% 1413
2016
Q4 		$1.71M Sell
51,981
-874
-2% -$26.2K ﹤0.01% 1094
2016
Q3 		$1.67M Buy
52,855
+9,100
+21% +$264K ﹤0.01% 1101
2016
Q2 		$1.23M Buy
43,755
+9,515
+28% +$373K ﹤0.01% 1178
2016
Q1 		$1.25M Sell
34,240
-24,055
-41% -$850K ﹤0.01% 1173
2015
Q4 		$2.33M Hold
58,295
– – 0.01% 962
2015
Q3 		$1.66M Sell
58,295
-3,743
-6% -$123K ﹤0.01% 1070
2015
Q2 		$2.04M Sell
62,038
-2,099
-3% -$65.1K ﹤0.01% 1055
2015
Q1 		$1.84M Sell
64,137
-33,096
-34% -$949K ﹤0.01% 1122
2014
Q4 		$2.65M Hold
97,233
– – 0.01% 993
2014
Q3 		$2.07M Sell
97,233
-9,421
-9% -$216K ﹤0.01% 1058
2014
Q2 		$2.4M Buy
106,654
+32,863
+45% +$765K 0.01% 1026
2014
Q1 		$1.86M Buy
73,791
+29,294
+66% +$740K ﹤0.01% 1141
2013
Q4 		$1.02M Hold
44,497
– – ﹤0.01% 1446
2013
Q3 		$848K Hold
44,497
– – ﹤0.01% 1525
2013
Q2 		$642K Buy
+44,497
New +$644K ﹤0.01% 1649

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

VOYA Investment Management's EBS Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 10,371 shares worth $86.9K. The stake represents ﹤0.01% of the portfolio and ranks #2371 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in EBS as recently as Q2 2025.

VOYA Investment Management first reported a position in EBS in Q2 2013 and has held it in 46 quarters since. The position peaked at $22M in Q2 2019. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • VOYA Investment Management held 10,371 shares of Emergent Biosolutions worth $86.9K as of Q2 2026.
  • Emergent Biosolutions was a new VOYA Investment Management position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2371 holding.
  • VOYA Investment Management first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 46 quarters since.
  • VOYA Investment Management's Emergent Biosolutions position peaked at $22M in Q2 2019.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.